Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
8.34 0.00(0.00%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 10,567   2,389   821   3,554  
Cost of Revenue -   -   -   -  
Gross Profit 10,567   2,389   821   3,554  
Operating Expenses
Research Development15,614  7,977  11,728  7,411  
Selling General and Administrative1,270  1,337  1,231  1,382  
Non Recurring17   -  4  77  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (6,334) (6,925) (12,142) (5,316)
Income from Continuing Operations
Total Other Income/Expenses Net2,147  115  1,135  1,990  
Earnings Before Interest And Taxes(4,187)(6,810)(11,007)(3,326)
Interest Expense1,242  1,191  1,165  1,180  
Income Before Tax(5,429)(8,001)(12,172)(4,506)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,429)(8,001)(12,172)(4,506)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,429) (8,001) (12,172) (4,506)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,429) (8,001) (12,172) (4,506)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.